It is concluded that:
- DART provides clear evidence to help governments and policymakers
determine priorities for ART programmes
- DART adds to the evidence base for ART in Africa in ways beyond those
- DART created highly skilled teams of ART clinical trialists and
centres of ART and research excellence in Uganda and Zimbabwe
- Partnerships have been developed,additional resources leveraged and a
broader scientific agenda realised
Presented at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, 19-22 July 2009, 22 pp.
The Development of Anti-Retroviral Therapy in Africa (DART) trial. What have we learnt?